Amanote Research
Register
Sign In
A Systematic Study of Nitrated Indenoisoquinolines Reveals a Potent Topoisomerase I Inhibitor
doi 10.1021/jm060974n.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
The Deubiquitinating Enzyme Inhibitor PR-619 Is a Potent DNA Topoisomerase II Poison
Molecular Pharmacology
Molecular Medicine
Pharmacology
Bioavailability and Pharmacokinetics of Oral Topotecan: A New Topoisomerase I Inhibitor
British Journal of Cancer
Cancer Research
Oncology
Diospyrin, a Bisnaphthoquinone: A Novel Inhibitor of Type I DNA Topoisomerase ofLeishmania Donovani
Molecular Pharmacology
Molecular Medicine
Pharmacology
Phase I and Pharmacological Study of the New Topoisomerase I Inhibitor GI147211, Using a Daily X 5 Intravenous Administration
British Journal of Cancer
Cancer Research
Oncology
Platelet Aggregation Inhibitors. I. Hydroxylamine: A Potent Inhibitor of Platelet Aggregation
Chemical and Pharmaceutical Bulletin
Medicine
Drug Discovery
Chemistry
Molecular and Cytotoxic Effects of Camptothecin, a Topoisomerase I Inhibitor, on Trypanosomes and Leishmania.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
“Nojirimycin” as a Potent Inhibitor of Glucosidase
Agricultural and Biological Chemistry
XR5944: A Potent Inhibitor of Estrogen Receptors
Molecular Cancer Therapeutics
Cancer Research
Oncology
Topostin, a Novel Inhibitor of Mammalian DNA Topoisomerase I From Flexibacter Topostinus Sp. Nov. I. Taxonomy, and Fermentation of Producing Strain.
Journal of Antibiotics
Drug Discovery
Pharmacology
